Vitamin C for triglyceride levels in ICU patients
Part of Hormones & metabolism clinical trials.
This trial looks at whether giving vitamin C through an IV can help lower triglyceride levels in patients in the intensive care unit. It compares patients who received vitamin C with similar patients who did not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 99 years old.
- You were admitted to a general intensive care unit (ICU) between January 2017 and December 2023.
- You were treated with intravenous (IV) vitamin C during your ICU stay.
- Your medical records are complete and available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if eating foods rich in omega-3 fats (like fish and nuts) can lower your triglycerides and improve cholesterol levels. It may help if you have moderately high triglycerides but no other serious health conditions.
This trial tests whether starting vitamin D3 soon after ICU admission helps critically ill adults with low vitamin D levels. It may help correct low vitamin D and possibly improve recovery, depending on your health situation.
This study tests whether giving high-dose vitamin C can help improve kidney function in people with severe liver failure, sudden kidney injury, and a serious infection with very low blood pressure. It's a randomized trial, meaning half the participants get vitamin C and half get a placebo, to see which group does better.
This early-stage study tests whether vitamin C (and possibly how your body uses it) affects blood vessel function in people with obesity and insulin resistance. You may be asked to stop certain supplements before starting so researchers can measure the effect more clearly.
This study tests whether giving very high doses of vitamin D to patients with sepsis in the intensive care unit (ICU) can improve their recovery. It focuses on adults aged 18 and older who have just been diagnosed with sepsis and are expected to stay in the ICU for at least a week.
This trial tests a combination of CYTOFLAVIN (given as an IV and later as a pill) to help people with long-term symptoms after spending time in the ICU. It aims to improve muscle weakness, breathing, swallowing, and energy levels during later stages of rehabilitation.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.